Laddar...
Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T
BACKGROUND: Patients with metastatic, castration-resistant prostate cancer (mCRPC) present with an increased tumor burden in the skeleton. For these patients, Lutetium-177 (Lu-177) radioligand therapy targeting the prostate-specific membrane antigen (PSMA) has gained increasing interest with promisi...
Sparad:
| I publikationen: | EJNMMI Phys |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952490/ https://ncbi.nlm.nih.gov/pubmed/33709253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-021-00369-4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|